On Saturday, April 14th, The Leukemia & Lymphoma Society’s (LLS) Connecticut Chapter will host Hops & Grapes, Toasts & Tastes for the third year at Stepping Stones Museum for Children in Norwalk, CT.
Local restaurants, vineyards, and distributors will come together to showcase a selection of appetizers, wines, and beers to over 250 people throughout the Fairfield County area.
Tasting sponsors to date include: American Harvest Vodka, Back East Brewing Company, Barcelona Restaurant, Bartaco, BJ Ryan's BANC House, Butterfield8, Cabot Cheese, Café D'Azur, Cake Suite, Chocolations, Cupcakes & Milkshakes, Dichello Distributors, Dina! A Restaurant & Bar, Ducky Life Teas, Karen Harvey Catering, Little Pub, New England Wine & Spirits, Nolet's Gin, O'Neills Irish Pub & Restaurant, Opici Wine Company of CT, Pink Cupcake Shack, Pizzeria Rosso, Regatta Ginger Beer, S. Pellegrino & Aqua Panna, Savor, Star Distributors, Starbucks, Sweets By Stella, Wave Hill Breads Bakery & Cafe.
Event is from 7:30pm to 10:30pm, event tickets $75 each, two for $125. VIP tickets are also available at $100 each or $175 for two and include a souvenir wine glass, LLS Relentless wristband, raffle ticket, and deluxe gift bag. Call 203-665-1400 for information or reservations or visit www.lls.org/ct/toastsandtastes
LLS hopes to raise over $50,000 during this fun filled evening. A silent auction and raffle will also take place. Raffle prizes donated by Hyatt Regency Greenwich, Capital Grille, Brewer’s Hardware, and The Rugg Family. Don’t miss the fun!
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society®, headquartered in White Plains, NY, with 58 chapters in the United States and Canada, is the world’s largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. LLS’ mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, LLS has invested more than $750 million in research specifically targeting leukemia, lymphoma and myeloma.